Transcutaneous Electrical Stimulation for Stroke Patients
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorShirley Ryan AbilityLab
About this trial
This study aims to evaluate the feasibility and impact of transcutaneous electrical stimulation of the spinal cord (TESS) on the recovery of post-stroke individuals who have upper limb hemiparesis. It will compare outcomes measures between individuals who receive upper limb task specific training with TESS and individuals who receive task specific training of the upper limb with Sham, or fake, TESS.
Eligibility criteria
Qualifiers
18 years or older
able and willing to give written consent and comply with study procedures
at least 6 months post-stroke
hemiplegia secondary to stroke
Disqualifiers
botox injection in upper extremity within the last 4 months
modified ashworth score of 4 in any joint of the affected limb
pregnant or nursing
using a powered, implanted cardiac device for monitoring or support of heart function (i.e. pacemaker, defibrillator, or LVAD), or anti-spasticity implantable pumps, or cochlear implants
Trial design
Treatments tested in this trial
- Task Specific Training (TST)
- Transcutaneous electrical spinal cord stimulation (TESS)
- Sham transcutaneous electrical spinal cord stimulation (Sham TESS)
Treatment groups
14 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov